Lease of chemistry assays analyzer / reagents
Ended Definitive Contract Awarded Last action
- Contract number
- W9114F20L0001
- Awardee
-
Horiba ABX SAS Societe Par Actions Simplifiee UEI FMM8NNK3LEU3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $129,403
Award facts
- Opportunity
-
- W9114F20Q0066 Solicitation number
- Contract value 78% obligated
-
- $162,966.74 Current, with exercised options
- $165,412.31 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Italy
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$71 | |
| Exercise an Option | $30,071 | |
| Supplemental Agreement for work within scope | $337 | |
| Exercise an Option | $31,408 | |
| Supplemental Agreement for work within scope | $291 | |
| Exercise an Option | $32,536 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $34,832 |
About this award
The Defense Health Agency awarded a definitive firm fixed price contract to Horiba ABX SAS Societe Par Actions Simplifiee (UEI: FMM8NNK3LEU3) on July 27, 2020, for the lease of a chemistry assays analyzer and associated reagents. The contract carries a ceiling value of $165,412.31 and is scheduled for ultimate completion by August 31, 2025. This procurement supports clinical laboratory operations, as chemistry analyzers and reagents are essential diagnostic tools used in medical facilities to process patient samples and deliver critical test results for patient care and treatment decisions.
The work will be performed in Italy, and no set-aside designation was applied to this contract. The Defense Health Agency, which provides health services and medical support to the Department of Defense and its beneficiaries, funded this acquisition to support laboratory capabilities at its facilities or partner healthcare installations. As a lease arrangement rather than a purchase, this contract provides the agency with access to analytical equipment while maintaining flexibility in technology upgrades and maintenance support throughout the performance period.
Quick answers
Who was awarded contract W9114F20L0001?
W9114F20L0001 was awarded to Horiba ABX SAS Societe Par Actions Simplifiee by Medical Command (Department of the Army) on July 27, 2020.
How much is contract W9114F20L0001 worth?
The government has obligated $129,403 on W9114F20L0001. Its current value, with exercised options, is $162,967. Its potential value, with all options, is $165,412.
Which agency awarded contract W9114F20L0001?
Medical Command (Department of the Army) awarded W9114F20L0001, with funding from Defense Health Agency (Department of Defense).
Was contract W9114F20L0001 competed?
The extent of competition for W9114F20L0001 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award